Contralateral delayed hematoma secondary to anticoagulant treatment-related intracerebral hemorrhage

Neuro Endocrinol Lett. 2013;34(5):343-6.

Abstract

The incidence of anticoagulant treatment (AT)-related intracerebral hemorrhage (AT-ICH) is increasing in consequence of the increased incidence of ischemic stroke due to an aging population. AT-ICH is associated with a risk of ongoing bleeding, death, or disability. Cerebral amyloid angiopathy (CAA), a common pathological finding among the elderly that is associated with macro- and microscopic hematoma development, might increase the risk of ICH. We report a rare case of contralateral delayed hematoma in the context of CAA secondary to acute ICH after AT for intracerebral ischemic stroke.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use
  • Cerebral Amyloid Angiopathy / complications
  • Cerebral Amyloid Angiopathy / drug therapy*
  • Cerebral Hemorrhage / chemically induced*
  • Cerebral Hemorrhage / complications
  • Hematoma / complications*
  • Humans
  • Male

Substances

  • Anticoagulants